Sonja Herter

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Dynamic BH3 profiling predicts clinical outcomes in acute myeloid leukemia.

Dynamic BH3 profiling predicts clinical outcomes in acute myeloid leukemia.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

Integration and validation of complementary ex vivo assays for functional precision oncology.

Integration and validation of complementary ex vivo assays for functional precision oncology.

Journal: NPJ precision oncology

Published: October 30, 2025

New cell lines expanding the diversity of Ewing sarcoma models.

New cell lines expanding the diversity of Ewing sarcoma models.

Journal: International journal of cancer

Published: March 24, 2025

A dependency map enhanced with next-generation 3D cancer models.

A dependency map enhanced with next-generation 3D cancer models.

Journal: Nature

Published: February 11, 2025

High content-imaging drug synergy screening identifies specific senescence-related vulnerabilities of mesenchymal neuroblastomas.

High content-imaging drug synergy screening identifies specific senescence-related vulnerabilities of mesenchymal neuroblastomas.

Journal: Cell death & disease

Published: November 01, 2024

Rebound growth of BRAF mutant pediatric glioma cells after MAPKi withdrawal is associated with MAPK reactivation and secretion of microglia-recruiting cytokines.

Rebound growth of BRAF mutant pediatric glioma cells after MAPKi withdrawal is associated with MAPK reactivation and secretion of microglia-recruiting cytokines.

Journal: Journal of neuro-oncology

Published: February 27, 2024

Synergy of retinoic acid and BH3 mimetics in MYC(N)-driven embryonal nervous system tumours.

Synergy of retinoic acid and BH3 mimetics in MYC(N)-driven embryonal nervous system tumours.

Journal: British journal of cancer

Published: November 10, 2023

ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma models through P-glycoprotein.

ERBB and P-glycoprotein inhibitors break resistance in relapsed neuroblastoma models through P-glycoprotein.

Journal: Molecular oncology

Published: August 26, 2022

Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM.

Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM.

Journal: NPJ precision oncology

Published: May 05, 2022

Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft Models.

Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft Models.

Journal: Cancers

Published: December 14, 2021

Showing 1-10 of 10

Last Updated: 09/26/2026